| From: Finlay Smith | 3/1/2024 11:06:09 AM | | | | | | | Attention! Endexx Corp. - $EDXC recently experienced a downturn due to a missed filing deadline. However, the exciting part is that once they resolve their paperwork issues, there's significant potential for a substantial upward surge. This might just be the rebound opportunity we've all been anticipating, so it's crucial to stay alert. Conduct thorough due diligence, but my intuition suggests that this could be a golden chance for gains. ???? Don't overlook this – it's shaping up to be a promising investment prospect! ?? To know more about them - Endexx Stock Report 2/29/24 (mailchi.mp) |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Giants1967 | 3/4/2024 11:04:45 AM | | | | | | Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey
Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a U.S. based medical device company focused on novel electrophysiology products, announced that VIVO was used for the first time on a pediatric patient in Turkey. The Company recently announced its new distribution partnership with Ege Artimi in Turkey in January.
Catheter Precision's CEO, David Jenkins, said, "VIVO is an excellent choice for pre-procedure planning, especially in pediatric patients. VIVO is non-invasive and used prior to ventricular ablations, meaning that it can provide the physician with additional information specific to each patient and because it is non-invasive there is no additional risk when it is utilized. The utilization of VIVO in delicate patient populations like this continues to show the flexibility and many benefits of this innovative product."
accesswire.com |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: getlouied | 3/15/2024 1:24:42 PM | | | | | | Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
globenewswire.com
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that it will report its financial results for the year ended 2023 and host a corporate update conference call on Thursday, March 28, 2024.
Conference Call Information
Date: Thursday, March 28, 2024
Time: 5:00 p.m. Eastern Time
Dial-in numbers: Toll Free: 877-407-0784; International +1-201-689-8560
Conference ID: 1650830
Webcast Link: globenewswire.com. An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com. To access the replay of the webcast, please follow the webcast link above.
If you have any questions that you would like to ask management during the Q&A session, please email hzosiak@dyadic.com prior to the conference call. |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Giants1967 | 3/22/2024 10:15:23 AM | | | | | | HNRC Financial Results: Twelve Months December 31, 2023 vs Twelve Months December 31, 2022
- Total revenue for twelve months was $ 21,117,265 vs $ 20,516,899,an increase of 2.9 %.
- Total earnings for twelve months were $ 11,501,687 vs $ 9,641,297,an increase of 19.3 %.
- Earnings per share for twelve months were $ 0.06 per share.
- The company has a net asset value of $ 0.42 per share as of December 31, 2023.
- https://www.prnewswire.com/news-releases/hnrc-reports-results-for-period-ending-december-31-2023-302092317.html
|
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Finlay Smith | 3/22/2024 12:43:38 PM | | | | | | $EDXC - Endexx Corporation is poised for massive success in the plant-based wellness and vape market. With expansions across the Middle East and Europe, their HYLA division is capturing diverse consumer bases. Plus, upcoming name and symbol change signals a potential surge in stock performance. Get in now before the market catches on!
marketsherald.com |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: getlouied | 3/25/2024 2:04:34 PM | | | | | | March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
https://thestreetreports.com/march-madness-2024-key-players-in-medical-tech-healthcare-and-ai-inbs-amtx-vtak-angh-trug/
Throughout March 2024, several sectors have captured investors’ interest, with the medical sector standing out prominently. Let’s delve into five key movers within this sector.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) a prominent player in the medical technology sector, renowned for its groundbreaking development of rapid, intelligent, and non-invasive testing solutions. On March 21, 2024, Ladenburg Thalmann, a “long-standing stalwart” Wall Street firm since 1876, issued a “Buy” recommendation on Intelligent Bio. For more information, visit this link:
Additionally, in March, Intelligent Bio announced the successful closure of a $10.1 million private offering, further establishing its position as an entity worth monitoring closely.
Aemetis Inc. (NASDAQ: AMTX) gained attention on March 8, 2024, when it announced its financial results for the fourth fiscal quarter and the full year ending December 31, 2023. The company, known for its renewable fuels and renewable natural gas, reported a remarkable 175% year-on-year growth in its biodiesel business in India, generating $77.2 million in sales. This growth significantly boosted the company amidst a fiscal year where it experienced a net loss of $46.3 million. Moreover, Aemetis achieved a significant milestone by securing $50 million in USDA-backed funding for dairy digesters during the period.
Catheter Precision Inc. (NYSE American: VTAK), a US-based medical device company specializing in electrophysiology products and featured in “MedTech Outlook”,” is proud to sponsor a session at the upcoming USA Arrhythmia Course in Monaco. The company’s VIVO and LockeT products have seen significant US and International adoption, leading to several bullish indicators in its stock. It is currently in a consolidation phase, hinting at a potential buying opportunity and a potential move into a higher trading range.
Anghami Inc. (NASDAQ: ANGH) is the operator of the most popular music and entertainment platform in the MENA (Middle East and North Africa) region. On March 12, the company made a significant announcement regarding its partnership. Anghami Inc. revealed that it had extended its partnership with Rotana Music, the leading independent record label in the Arab world. The initial collaboration between the two entities was established in 2012, and this latest expansion represents a major milestone in their partnership. Through this renewed commitment, Anghami and Rotana Music will collaborate on a wider range of projects and releases across various content formats over the next three years.
TruGolf Holdings Inc. (NASDAQ: TRUG) is a major player in the distribution and sale of golf simulator hardware and software. On March 20, the company announced a definitive agreement with mISpatial, a renowned firm specializing in AI and machine learning engineering. This collaboration involves licensing mISpatial’s AI engine, which was co-developed, to enhance the spin accuracy of the 9-axis spin in TruGolf Holdings’ popular new APOGEE launch monitor. Furthermore, as part of the agreement, the company gains the first right of refusal to sell any assets belonging to mISpatial. |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Finlay Smith | 3/28/2024 1:33:37 PM | | | | | | $IQST - iQSTEL is on fire lately! Massive volume, fresh buyers pouring in, and the buzz around the new acquisition is electrifying. We're talking BILLION-dollar revenue territory! Don't miss out – it's a BUY!
youtu.be |
| | Rat dog micro-cap picks... | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
